Corrigendum to “Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus” Journal of Clinical Virology 45 (2009) 54–60 (Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus (2009) 45(1) (54–60), (S1386653209000870), (10.1016/j.jcv.2009.02.011));Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus

Journal of Clinical Virology

Volumn 45, Issue 1, 2009, Pages 54-60

  Chan, C M ^a,b,c   Tse, Herman ^a,b,c   Wong, S S Y ^a,b,c   Woo, P C Y ^a,b,c   Lau, S K P ^a,b,c   Chen, L ^a,b,c   Zheng, B J ^a,b,c   Huang, J D ^a,b,c   Yuen, K Y ^a,b,c  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c GUANGZHOU INSTITUTES OF BIOMEDICINE AND HEALTH   (China)

Author keywords

Human coronavirus HKU1; Neutralization antibody; Seroepidemiology; Spike

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; NUCLEOCAPSID PROTEIN; VIRUS SPIKE PROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; CORONAVIRUS; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CORONAVIRUS HKU1; IMMUNOFLUORESCENCE; INFANT; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPING; SEROEPIDEMIOLOGY; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS SPIKE; WESTERN BLOTTING;

EID: 67349188881     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2022.105295     Document Type: Erratum

References (36)

1. Bisht H., Roberts A., Vogel L., Bukreyev A., Collins P.L., Murphy B.R., et al. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci USA 101 17 (2004) 6641-6646
2. Bisht H., Roberts A., Vogel L., Subbarao K., and Moss B. Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein. Virology 334 2 (2005) 160-165
3. Bosch B.J., de Haan C.A., Smits S.L., and Rottier P.J. Spike protein assembly into the coronavirion: exploring the limits of its sequence requirements. Virology 334 2 (2005) 306-318
4. Bosis S., Esposito S., Niesters H.G., Tremolati E., Pas S., Principi N., et al. Coronavirus HKU1 in an Italian pre-term infant with bronchiolitis. J Clin Virol 38 3 (2007) 251-253
5. Chan C.M., Woo P.C.Y., Lau S.K.P., Tse H., Chen H.L., Li F., et al. Spike protein of human coronavirus HKU1: role in viral life cycle and antibody detection. Exp Biol Med (Maywood) 233 12 (2008) 1527-1536
6. Chang L.J., Urlacher V., Iwakuma T., Cui Y., and Zucali J. Efficacy and safety analyses of a recombinant human immunodeficiency virus type 1 derived vector system. Gene Ther 6 5 (1999) 715-728
7. Chung J.Y., Han T.H., Kim S.W., Kim C.K., and Hwang E.S. Detection of viruses identified recently in children with acute wheezing. J Med Virol 79 8 (2007) 1238-1243
8. Du L., Zhao G., He Y., Guo Y., Zheng B.J., Jiang S., et al. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine 25 15 (2007) 2832-2838
9. Esper F., Weibel C., Ferguson D., Landry M.L., and Kahn J.S. Coronavirus HKU1 infection in the United States. Emerg Infect Dis 12 5 (2006) 775-779
10. Esposito S., Bosis S., Niesters H.G., Tremolati E., Begliatti E., Rognoni A., et al. Impact of human coronavirus infections in otherwise healthy children who attended an emergency department. J Med Virol 78 12 (2006) 1609-1615
11. Freymuth F., Vabret A., Dina J., Petitjean J., and Gouarin S. Techniques used for the diagnostic of upper and lower respiratory tract viral infections. Rev Prat 57 17 (2007) 1876-1882
12. Fukushi S., Mizutani T., Saijo M., Kurane I., Taguchi F., Tashiro M., et al. Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. J Med Virol 78 12 (2006) 1509-1512
13. Garbino J., Crespo S., Aubert J.D., Rochat T., Ninet B., Deffernez C., et al. A prospective hospital-based study of the clinical impact of non-severe acute respiratory syndrome (Non-SARS)-related human coronavirus infection. Clin Infect Dis 43 8 (2006) 1009-1015
14. Gerna G., Percivalle E., Sarasini A., Campanini G., Piralla A., Rovida F., et al. Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol 38 3 (2007) 244-250
15. Hofmann H., Pyrc K., van der Hoek L., Geier M., Berkhout B., and Pohlmann S. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA 102 22 (2005) 7988-7993
16. Holmes K.V. Coronaviruses. In: Fields B.N., Knipe D.M., Howley P.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Straus S.E. (Eds). Fields Virology. 4th ed. (2001), Lippincott, Williams & Wilkins, Philadelphia 1187-1203
17. Kistler A., Avila P.C., Rouskin S., Wang D., Ward T., Yagi S., et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 196 6 (2007) 817-825
18. Kupfer B., Simon A., Jonassen C.M., Viazov S., Ditt V., Tillmann R.L., et al. Two cases of severe obstructive pneumonia associated with an HKU1-like coronavirus. Eur J Med Res 12 3 (2007) 134-138
19. Kuypers J., Martin E.T., Heugel J., Wright N., Morrow R., and Englund J.A. Clinical disease in children associated with newly described coronavirus subtypes. Pediatrics 119 1 (2007) e70-76
20. Kwan L.C., Ho Y.Y., and Lee S.S. The declining HBsAg carriage rate in pregnant women in Hong Kong. Epidemiol Infect 119 2 (1997) 281-283
21. Lau S.K., Woo P.C., Yip C.C., Tse H., Tsoi H.W., Cheng V.C., et al. HKU1 and other coronavirus infections in Hong Kong. J Clin Microbiol 44 6 (2006) 2063-2071
22. Maache M., Komurian-Pradel F., Rajoharison A., Perret M., Berland J.L., Pouzol S., et al. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. Clin Vaccine Immunol 13 3 (2006) 409-414
23. Ndifuna A., Waters A.K., Zhou M., and Collisson E.W. Recombinant nucleocapsid protein is potentially an inexpensive, effective serodiagnostic reagent for infectious bronchitis virus. J Virol Methods 70 1 (1998) 37-44
24. Nie Y., Wang G., Shi X., Zhang H., Qiu Y., He Z., et al. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection. J Infect Dis 190 6 (2004) 1119-1126
25. Pierangeli A., Gentile M., Di Marco P., Pagnotti P., Scagnolari C., Trombetti S., et al. Detection and typing by molecular techniques of respiratory viruses in children hospitalized for acute respiratory infection in Rome Italy. J Med Virol 79 4 (2007) 463-468
26. Sloots T.P., McErlean P., Speicher D.J., Arden K.E., Nissen M.D., and Mackay I.M. Evidence of human coronavirus HKU1 and human bocavirus in Australian children. J Clin Virol 35 1 (2006) 99-102
27. Smerdou C., and Liljestrom P. Two-helper RNA system for production of recombinant Semliki forest virus particles. J Virol 73 2 (1999) 1092-1098
28. Srivastava I.K., Ulmer J.B., and Barnett S.W. Role of neutralizing antibodies in protective immunity against HIV. Hum Vaccine 1 2 (2005) 45-60
29. St-Jean J.R., Desforges M., Almazan F., Jacomy H., Enjuanes L., and Talbot P.J. Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone. J Virol 80 7 (2006) 3670-3674
30. Temperton N.J., Chan P.K., Simmons G., Zambon M.C., Tedder R.S., Takeuchi Y., et al. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis 11 3 (2005) 411-416
31. Thiel V., Herold J., Schelle B., and Siddell S.G. Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol 82 Pt 6 (2001) 1273-1281
32. Vabret A., Dina J., Gouarin S., Petitjean J., Corbet S., and Freymuth F. Detection of the new human coronavirus HKU1: a report of 6 cases. Clin Infect Dis 42 5 (2006) 634-639
33. Woo P.C., Lau S.K., Chu C.M., Chan K.H., Tsoi H.W., Huang Y., et al. Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia. J Virol 79 2 (2005) 884-895
34. Woo P.C., Lau S.K., Tsoi H.W., Huang Y., Poon R.W., Chu C.M., et al. Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia. J Infect Dis 192 11 (2005) 1898-1907
35. Woo P.C., Lau S.K., Wong B.H., Chan K.H., Hui W.T., Kwan G.S., et al. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol 42 12 (2004) 5885-5888
36. Zhou T., Wang H., Luo D., Rowe T., Wang Z., Hogan R.J., et al. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies. J Virol 78 13 (2004) 7217-7226